US 9845350
Monoclonal antibodies that react with the capsule of bacillus anthracis
granted A61KA61K2039/505A61K39/07
Quick answer
US patent 9845350 (Monoclonal antibodies that react with the capsule of bacillus anthracis) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2039/505, A61K39/07, A61K39/3955, A61K39/40